EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

Eyebright Medical Technology (Beijing) Co., Ltd.

688050

CNE1000041J5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
141.5 ^CNY	+2.65%		+5.13%	-17.75%

Apr. 17	Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Eyebright Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.	CI

Eyebright Medical Technology Co., Ltd. authorizes a Buyback Plan.

February 21, 2024

The Board of Directors of Eyebright Medical Technology (Beijing) Co., Ltd. has authorized a buyback plan on February 22, 2024.

Latest news about Eyebright Medical Technology (Beijing) Co., Ltd.

Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 17	CI
Tranche Update on Eyebright Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.	Apr. 01	CI
Eyebright Medical Technology Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	Feb. 23	CI
Eyebright Medical Technology Co., Ltd. authorizes a Buyback Plan.	Feb. 21	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 06	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Eyebright Medical Technology Co., Ltd.(XSSC:688050) added to S&P Global BMI Index	23-09-18	CI
Eyebright Medical Technology Co., Ltd.(XSSC:688050) added to FTSE All-World Index	23-09-18	CI
Eyebright Medical Technology Plans GDR Issue to Fund Projects, Boost Capital	23-08-17	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Eyebright Medical Technology's Phakic Intraocular Lens Pass Special Review	23-08-10	MT
Eyebright Medical Technology Co., Ltd. agreed to acquire additional 14.1579% stake in Fujian Unicon Optical Co., Ltd from Hong Kong Unicon Optical Co. for CNY 70.1 million.	23-07-30	CI
Certain A Shares of Eyebright Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-JUL-2023.	23-07-28	CI
Fujian Unicon Optical Co., Ltd announced that it expects to receive CNY 175 million in funding from Eyebright Medical Technology Co., Ltd.	23-07-27	CI
IB Settlement Unit in Negotiations to Receive 100 Million Yuan Capital Injection from Eyebright Medical	23-05-12	MT
Fujian Unicon Optical Co., Ltd announced that it expects to receive CNY 100 million in funding from Eyebright Medical Technology Co., Ltd.	23-05-11	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Eyebright Medical Technology Logs 35.3% Jump in 2022 Profit	23-02-15	MT
Eyebright Medical Technology Gets Conditional Nod For Swiss IPO	23-02-09	MT
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-17	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Tianjin Zhengli Technology Co., Ltd. announced that it has received $15.7 million in funding from 3E Bioventures Capital, Eyebright Medical Technology Co., Ltd. and another investor	21-12-28	CI
Eyebright Medical Technology Co., Ltd.(SHSE:688050) added to Shanghai Stock Exchange Health Care Sector Index	21-12-13	CI

Chart Eyebright Medical Technology (Beijing) Co., Ltd.

Duration

Period

Chart Eyebright Medical Technology (Beijing) Co., Ltd.

More charts

Eyebright Medical Technology Beijing Co Ltd is a China-based company principally involved in the research, development, manufacturing and sales of ophthalmic medical devices. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The Company conducts its businesses in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Eyebright Medical Technology (Beijing) Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

141.5 CNY

Average target price

214.5 CNY

Spread / Average Target

+51.59%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-17.75%	2.06B
STRAUMANN HOLDING AG	+1.84%	24.07B
SONOVA HOLDING AG	-6.34%	16.75B
DEMANT A/S	+10.34%	10.18B
EMBLA MEDICAL HF.	+6.38%	1.79B
ANGELALIGN TECHNOLOGY INC.	+41.47%	1.73B
MODERN DENTAL GROUP LIMITED	+13.26%	589M
ANGEL ROBOTICS CO., LTD.	0.00%	400M
DELCATH SYSTEMS, INC.	+27.40%	135M
INTEGRUM AB	+21.80%	93.49M

Medical Prosthetics

Eyebright Medical Technology (Beijing) Co., Ltd.

Equities

688050

CNE1000041J5

Medical Equipment, Supplies & Distribution

Eyebright Medical Technology Co., Ltd. authorizes a Buyback Plan.

Latest news about Eyebright Medical Technology (Beijing) Co., Ltd.

Chart Eyebright Medical Technology (Beijing) Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Eyebright Medical Technology (Beijing) Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Prosthetics